Fig. 5From: Evaluating the role of cytokinesis-block micronucleus assay as a biomarker for oxidative stress-inducing DNA damage in type 2 diabetes mellitus patientsMN frequency obtained for control and type 2 diabetes mellitus patients. ***P value < 0.0001Back to article page